Dennis Gillings, founder of Quintiles Transnational Holdings Inc., which is now part of Iqvia Holdings Inc., has retired from the company’s board, according to a Securities and Exchange Commission filing here.

Gillings retirement came after the 2016 merger of Quintiles and IMS Health Holdings Inc. He still holds approximately 10 million shares of Iqvia stock.

Gillings was elected as the lead director through the 2018 annual meeting of stockholders, held on April 10. Following the meeting, Gillings retired from the board of directors.

Gillings’ retirement was not due to any disagreement on any matter relating to the company’s operations, policies, or practices.

Gillings was formerly a professor of biostatistics at UNC-Chapel Hill and has received honorary DSc degrees from UNC, Southampton University, and Exeter University.

In 2004, Gillings was honored by the Queen as Commander of the Most Excellent Order of the British Empire for services to the Pharmaceutical industry.

In 2012 he received the SCRIP Lifetime Achievement Award in recognition of contributions to pharmaceuticals.

Iqvia is a human data science company. The company provides solutions that enable life sciences companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward.

Iqvia provides actionable solutions by tapping into domain expertise, advances analytics,unparalleled data and transformative technology.

The merger occurred 2016, and the company has roughly 10,000 employees.

Iqvia’s stock closed Thursday at $96.12, up 14 cents.